搜尋結果
香港國際機場 福岡 - 機票搜尋
Powered by
Search drug, interactions and image information in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia, India & USA Sotorasib-panitumumab combo shows positive OS trend in mCRC 26 Jun 2024 ...
Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.
Search company information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India.
Poison Classification for Hong Kong. Non-poison (NP) May be sold by medicine retailers. Part II poisons (P2) May be sold within the registered premises of an Authorised Seller of Poisons (ASP), commonly known as pharmacy or dispensary, or a Listed Seller of Poisons. Part 1 only Poisons (P1)
Treatment of uncomplicated flu in patients ≥12 yr. Post-exposure prophylaxis of flu in individuals ≥12 yr. Click to view Xofluza detailed prescribing information.
Febuxostat. Indications/Uses. Chronic hyperuricaemia in conditions where urate deposition has already occurred (including history, or presence of, tophus &/or gouty arthritis). Click to view Febuda detailed prescribing information. Dosage/Direction for Use. Adult 80 mg once daily. Click to view Febuda detailed prescribing information. Overdosage.
Dosage/Direction for Use. 10 mg once daily. Patient w/ severe hepatic impairment Initially 5 mg, may be increased to 10 mg if well tolerated. Click to view Forxiga detailed prescribing information.
